Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06312332 · ClinicalTrials.gov registry record · NA

Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)

A NA study of Pulmonary Embolism, sponsored by University of Michigan.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT06312332: Active NA study of Pulmonary Embolism, sponsored by University of Michigan.

NCT06312332 is a NA study of Pulmonary Embolism that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 14 participants, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06312332, a NA study of Pulmonary Embolism, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This study is a quality improvement project to evaluate health care management of pulmonary embolism (PE) patients. The researchers are testing an intervention to determine if it prevents unnecessary hospital admissions.

Primary Outcome

Reported by participating center indicating the proportion of patients discharged home from ED

Conditions Studied

Interventions

  • BEHAVIORAL Pulmonary Embolism (PE) Care in Emergency Department (ED)

Study Locations (1)

Michigan

  • Michigan Emergency Department Improvement Collaborative partners - Ann Arbor

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2024-03-01
Est. Completion 2026-08
Phase NA
University of Michigan

1,327 total trials

What the registry record for NCT06312332 still lists

NCT06312332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Pulmonary Embolism (PE) Care in Emergency Department (ED) is the first listed.

NCT06312332 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06312332 about?

NCT06312332 is a clinical study titled "Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)". This study is a quality improvement project to evaluate health care management of pulmonary embolism (PE) patients. The researchers are testing an intervention to determine if it prevents unnecessary hospital admissions.

What is the current status of trial NCT06312332?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2024-03-01. Estimated completion is 2026-08.

What conditions does trial NCT06312332 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT06312332?

The interventions under investigation include: Pulmonary Embolism (PE) Care in Emergency Department (ED) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06312332?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06312332 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06312332's enrollment target sits among peer trials

14 48th of 48 higher than 1 of 48 other Pulmonary Embolism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06312332, the US trial registry maintained by the National Library of Medicine. NCT06312332 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.